Holen Sie sich die Stockscreener-App
3.56
11.60%
0.37
Handel nachbörslich:
3.65
0.09
+2.53%
Schlusskurs vom Vortag:
$3.19
Offen:
$3.2
24-Stunden-Volumen:
867.67K
Relative Volume:
2.89
Marktkapitalisierung:
$192.08M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-2.3733
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
+30.40%
1M Leistung:
+38.52%
6M Leistung:
+27.14%
1J Leistung:
-31.14%
1-Tages-Spanne:
$3.10
$3.66
1-Wochen-Bereich:
$2.6616
$3.66
52-Wochen-Spanne:
$2.20
$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Vergleichen Sie OBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.56 | 172.12M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Orchestra BioMed to Highlight AVIM Therapy’s Potential to Transform Hypertension Care - MyChesCo
Will Orchestra BioMed Holdings Inc. stock beat EPS estimates2025 Market Overview & Verified High Yield Trade Plans - newser.com
Tools to monitor Orchestra BioMed Holdings Inc. recovery probabilityBond Market & AI Powered Market Trend Analysis - newser.com
Can Orchestra BioMed Holdings Inc. stock reach $100 price target2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Applying chart zones and confluence areas to Orchestra BioMed Holdings Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Using data filters to optimize entry into Orchestra BioMed Holdings Inc.Chart Signals & High Win Rate Trade Tips - newser.com
Orchestra BioMed Holdings Inc. stock momentum explained2025 Dividend Review & Community Shared Stock Ideas - newser.com
Orchestra BioMed (NASDAQ:OBIO) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
What does recent volatility data suggest for Orchestra BioMed Holdings Inc.July 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Orchestra BioMed to Showcase Transformative Potential of - GlobeNewswire
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit - Investing News Network
Orchestra BioMed Presents Comprehensive Data on AVIM Therapy for Hypertensive Heart Disease at Georgia Innovation Summit - Quiver Quantitative
15.6 mmHg Immediate aSBP Drop — Orchestra BioMed AVIM Data; FDA Breakthrough, Oct 10 - Stock Titan
What’s next for Orchestra BioMed Holdings Inc. stock priceJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Is Orchestra BioMed Holdings Inc a good long term investmentCapital Gains Strategies & Rapid Portfolio Appreciation - earlytimes.in
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
Full technical analysis of Orchestra BioMed Holdings Inc. stockTrade Analysis Report & Weekly High Return Stock Forecasts - newser.com
A activityEarnings Summary Report & Weekly High Potential Stock Alerts - newser.com
What institutional flow reveals about Orchestra BioMed Holdings Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Why Orchestra BioMed Holdings Inc. stock is seen as undervaluedPortfolio Gains Summary & Accurate Trade Setup Notifications - newser.com
Evaluating Orchestra BioMed Holdings Inc. with trendline analysis2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com
Automated trading signals detected on Orchestra BioMed Holdings Inc.Market Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Orchestra BioMed : Corporate Presentation October 2025 - MarketScreener
Published on: 2025-09-29 00:02:42 - newser.com
What analysts say about Orchestra BioMed Holdings Inc stockDividend Stock Watch & Interactive Learning for Better Returns - earlytimes.in
Orchestra Biomed Holdings Hits New 52-Week Low at $2.33 - Markets Mojo
Orchestra Biomed Holdings Hits New 52-Week Low at $2.20 - Markets Mojo
FDA Greenlights Broader Patient Access for AVIM Therapy Trial in Pacemaker Patients - MSN
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of “Buy” by Analysts - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of "Buy" by Analysts - MarketBeat
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):